Serve Robotics stock drops 3% then ticks higher after hours as year-end trading thins

Serve Robotics stock drops 3% then ticks higher after hours as year-end trading thins

NEW YORK, December 30, 2025, 01:22 ET — Market closed.

  • Serve Robotics closed down 3.25% at $9.81 and was last up about 2% in after-hours trade. MarketWatch
  • The move came as U.S. stocks dipped in light year-end volume, with tax-loss selling in focus. MarketScreener
  • Traders are watching whether SERV holds above Monday’s $9.77 low and the timing of the company’s next earnings update. Server Robotics Investors

Serve Robotics shares fell 3.25% on Monday to close at $9.81, then rose about 2% in after-hours trade. MarketWatch

The late-year backdrop matters for small-cap stocks like Serve, where lighter liquidity can exaggerate day-to-day moves. With fewer buyers and sellers around, even routine flows can push prices more than usual. MarketScreener

“It’s a very light trading week ahead; volume is low,” said Sam Stovall, chief investment strategist at CFRA Research, pointing to tax-loss harvesting — selling losing positions to offset capital gains for tax purposes. MarketScreener

Broader markets also leaned risk-off on Monday. U.S. stocks dipped as weakness in tech and materials weighed, while Treasury yields eased and the dollar hovered near its lowest level in almost three months on expectations of further Federal Reserve rate cuts next year, a Reuters report said. MarketScreener

Serve traded between $9.77 and $10.25 during the regular session, with about 4.27 million shares changing hands, according to the company’s historical quote data. Server Robotics Investors

The stock has slipped in two straight sessions and is down about 11% from its Dec. 22 close. StockAnalysis

Serve develops and operates low-emission robots for last-mile delivery services on its AI-powered robotics mobility platform, starting with food delivery. Reuters

For traders, the bigger question is whether the move is a year-end air pocket or the start of a deeper reset in high-volatility robotics names as investors rebalance into year-end. MarketScreener

Before the next session, chart-focused traders will watch whether the stock holds above Monday’s $9.77 low — an area often described as “support,” where buying interest has recently appeared — and whether it can retake $10.25, a nearby “resistance” level where selling showed up. Server Robotics Investors

The after-hours bounce back above $10 adds a near-term test: whether dip buyers show up again at the open, or if the rebound fades once regular liquidity returns. MarketWatch

The next major scheduled catalyst is earnings. Serve’s next report is expected around March 5, 2026, according to Zacks, though the company has not confirmed a date. Zacks

Until then, investors are likely to take their cue from broader risk appetite and any fresh company updates on deployments, partnerships or operating metrics — the kind of headlines that can move thinly traded small caps quickly, especially in year-end conditions. MarketScreener

Stock Market Today

  • Nifty Falls Below 25,600; Wipro Shares Dive 8% on Soft Q4 Outlook
    January 19, 2026, 8:17 PM EST. The NSE Nifty 50 index slipped 0.42% to close at 25,585.50 amid broad market weakness. IT giant Wipro plunged over 8% following a cautious fourth-quarter earnings outlook, fueling concerns around revenue and profit forecasts. Midcap and smallcap stocks also faced pressure, with the Nifty Midcap 150 down more than 0.5% and Nifty Smallcap 250 falling over 1%, reflecting risk-averse investor sentiment. Corporate activities included Mahamaya Steel Industries' potential promoter share freeze, Info Edge's Rs 10 crore subsidiary investment, and Arman Financial Services' Rs 125 crore debenture issue. Several Q3 earnings highlighted mixed results: LTIMindtree's revenue rose 3.7% but profit dropped 30.7%, Havells India showed strong revenue and EBITDA growth, while CEAT posted a 26% revenue increase with elevated EBITDA despite one-time losses.
Outlook Therapeutics stock jumps ahead of FDA’s Dec. 31 Lytenava decision
Previous Story

Outlook Therapeutics stock jumps ahead of FDA’s Dec. 31 Lytenava decision

Fannie Mae stock (FNMA) slides 4% into year-end as housing data and Fed minutes loom
Next Story

Fannie Mae stock (FNMA) slides 4% into year-end as housing data and Fed minutes loom

Go toTop